SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4y5x'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.92A	1zzrA-4y5xB: undetectable 1zzrB-4y5xB: undetectable	1zzrA-4y5xB: 14.52 1zzrB-4y5xB: 14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.94A	1zzrA-4y5xB: undetectable 1zzrB-4y5xB: undetectable	1zzrA-4y5xB: 14.52 1zzrB-4y5xB: 14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.92A	1zzuA-4y5xB: undetectable 1zzuB-4y5xB: undetectable	1zzuA-4y5xB: 14.52 1zzuB-4y5xB: 14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.92A	1zzuA-4y5xB: undetectable 1zzuB-4y5xB: undetectable	1zzuA-4y5xB: 14.52 1zzuB-4y5xB: 14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OLD_B_IPHB2001_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	4y5x	DIABODY 310 VL DOMAIN DIABODY 310 VH DOMAIN (Homo sapiens; Homo sapiens)	4 / 7	TYR A 95 TYR B 37 PRO B 45 TYR B 88	None	0.48A	2oldA-4y5xA: 13.0 2oldB-4y5xA: 13.1	2oldA-4y5xA: 25.57 2oldB-4y5xA: 25.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OLD_B_IPHB2001_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	4y5x	DIABODY 310 VL DOMAIN DIABODY 310 VH DOMAIN (Homo sapiens; Homo sapiens)	4 / 7	TYR B 37 PRO B 45 TYR B 88 TYR A 95	None	0.43A	2oldA-4y5xB: 20.7 2oldB-4y5xB: 20.9	2oldA-4y5xB: 35.29 2oldB-4y5xB: 35.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PNJ_A_CHDA501_0 (FERROCHELATASE, MITOCHONDRIAL)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	5 / 12	LEU B 4 ILE B 29 LEU B 55 PRO B 56 VAL B 59	None None None None PEG B 201 ( 4.8A)	1.08A	2pnjA-4y5xB: undetectable	2pnjA-4y5xB: 18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 8	LEU B 40 VAL B 109 ILE B 76 PHE B 63	None None None PEG B 201 (-4.7A)	0.97A	2weyB-4y5xB: undetectable	2weyB-4y5xB: 15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.95A	3dqrA-4y5xB: undetectable 3dqrB-4y5xB: undetectable	3dqrA-4y5xB: 14.45 3dqrB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.98A	3dqrA-4y5xB: undetectable 3dqrB-4y5xB: undetectable	3dqrA-4y5xB: 14.45 3dqrB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.89A	3jx2A-4y5xB: undetectable 3jx2B-4y5xB: undetectable	3jx2A-4y5xB: 14.45 3jx2B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.91A	3jx2A-4y5xB: undetectable 3jx2B-4y5xB: undetectable	3jx2A-4y5xB: 14.45 3jx2B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.94A	3jx3A-4y5xB: undetectable 3jx3B-4y5xB: undetectable	3jx3A-4y5xB: 14.45 3jx3B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.90A	3jx3A-4y5xB: undetectable 3jx3B-4y5xB: undetectable	3jx3A-4y5xB: 14.45 3jx3B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.93A	3jx4A-4y5xB: undetectable 3jx4B-4y5xB: undetectable	3jx4A-4y5xB: 14.45 3jx4B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.90A	3jx5A-4y5xB: undetectable 3jx5B-4y5xB: undetectable	3jx5A-4y5xB: 14.45 3jx5B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.91A	3jx5A-4y5xB: undetectable 3jx5B-4y5xB: undetectable	3jx5A-4y5xB: 14.45 3jx5B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.83A	3jx6A-4y5xB: undetectable 3jx6B-4y5xB: undetectable	3jx6A-4y5xB: 14.45 3jx6B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.87A	3jx6A-4y5xB: undetectable 3jx6B-4y5xB: undetectable	3jx6A-4y5xB: 14.45 3jx6B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.85A	3nljA-4y5xB: undetectable 3nljB-4y5xB: undetectable	3nljA-4y5xB: 14.45 3nljB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.87A	3nljA-4y5xB: undetectable 3nljB-4y5xB: undetectable	3nljA-4y5xB: 14.45 3nljB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.88A	3nlpA-4y5xB: undetectable 3nlpB-4y5xB: undetectable	3nlpA-4y5xB: 14.45 3nlpB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.92A	3nlpA-4y5xB: undetectable 3nlpB-4y5xB: undetectable	3nlpA-4y5xB: 14.45 3nlpB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 8	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.85A	3nlqA-4y5xB: undetectable 3nlqB-4y5xB: undetectable	3nlqA-4y5xB: 14.45 3nlqB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.88A	3nlqA-4y5xB: undetectable 3nlqB-4y5xB: undetectable	3nlqA-4y5xB: 14.45 3nlqB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.88A	3nlrA-4y5xB: undetectable 3nlrB-4y5xB: undetectable	3nlrA-4y5xB: 14.45 3nlrB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 8	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.91A	3nlrA-4y5xB: undetectable 3nlrB-4y5xB: undetectable	3nlrA-4y5xB: 14.45 3nlrB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.93A	4cx3A-4y5xB: undetectable 4cx3B-4y5xB: undetectable	4cx3A-4y5xB: 14.45 4cx3B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.91A	4cx3A-4y5xB: undetectable 4cx3B-4y5xB: undetectable	4cx3A-4y5xB: 14.45 4cx3B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.94A	4cx4A-4y5xB: undetectable 4cx4B-4y5xB: undetectable	4cx4A-4y5xB: 14.45 4cx4B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.92A	4cx4A-4y5xB: undetectable 4cx4B-4y5xB: undetectable	4cx4A-4y5xB: 14.45 4cx4B-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QGI_A_ROCA101_1 (PROTEASE)	4y5x	DIABODY 310 VL DOMAIN (Homo sapiens)	5 / 11	GLY A 105 ALA A 104 ILE A 51 THR A 58 VAL A 37	None	0.86A	4qgiA-4y5xA: undetectable	4qgiA-4y5xA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XDT_A_ACTA409_0 (FAD:PROTEIN FMN TRANSFERASE)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 5	VAL B 18 ILE B 20 VAL B 107 THR B 105	None	0.73A	4xdtA-4y5xB: undetectable	4xdtA-4y5xB: 15.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ACL_A_SASA1111_1 (MCG)	4y5x	DIABODY 310 VH DOMAIN DIABODY 310 VL DOMAIN (Homo sapiens)	4 / 7	TYR A 109 TYR B 37 TYR B 50 PRO B 56	None	0.80A	5aclA-4y5xA: 13.3	5aclA-4y5xA: 31.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.86A	5addA-4y5xB: undetectable 5addB-4y5xB: undetectable	5addA-4y5xB: 14.45 5addB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.85A	5adeA-4y5xB: undetectable 5adeB-4y5xB: undetectable	5adeA-4y5xB: 14.45 5adeB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	VAL B 109 ARG B 62 VAL B 18 GLU B 84	None	0.91A	5g0pA-4y5xB: undetectable 5g0pB-4y5xB: undetectable	5g0pA-4y5xB: 14.45 5g0pB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 7	GLU B 84 VAL B 109 ARG B 62 VAL B 18	None	0.92A	5g0pA-4y5xB: undetectable 5g0pB-4y5xB: undetectable	5g0pA-4y5xB: 14.45 5g0pB-4y5xB: 14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4y5x	DIABODY 310 VH DOMAIN (Homo sapiens)	4 / 8	THR B 19 SER B 64 ALA B 72 ASP B 52	None	1.08A	5l5fY-4y5xB: undetectable 5l5fZ-4y5xB: undetectable	5l5fY-4y5xB: 19.63 5l5fZ-4y5xB: 17.81

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.92A","1zzrA-4y5xB:undetectable;1zzrB-4y5xB:undetectable","1zzrA-4y5xB:14.52;1zzrB-4y5xB:14.52"],["1ZZR_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.94A","1zzrA-4y5xB:undetectable;1zzrB-4y5xB:undetectable","1zzrA-4y5xB:14.52;1zzrB-4y5xB:14.52"],["1ZZU_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.92A","1zzuA-4y5xB:undetectable;1zzuB-4y5xB:undetectable","1zzuA-4y5xB:14.52;1zzuB-4y5xB:14.52"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.92A","1zzuA-4y5xB:undetectable;1zzuB-4y5xB:undetectable","1zzuA-4y5xB:14.52;1zzuB-4y5xB:14.52"],["2OLD_B_IPHB2001_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","4y5x","DIABODY 310 VL DOMAIN;DIABODY 310 VH DOMAIN","Homo sapiens;Homo sapiens",4,"TYR A  95;TYR B  37;PRO B  45;TYR B  88","None","0.48A","2oldA-4y5xA:13.0;2oldB-4y5xA:13.1","2oldA-4y5xA:25.57;2oldB-4y5xA:25.57"],["2OLD_B_IPHB2001_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","4y5x","DIABODY 310 VL DOMAIN;DIABODY 310 VH DOMAIN","Homo sapiens;Homo sapiens",4,"TYR B  37;PRO B  45;TYR B  88;TYR A  95","None","0.43A","2oldA-4y5xB:20.7;2oldB-4y5xB:20.9","2oldA-4y5xB:35.29;2oldB-4y5xB:35.29"],["2PNJ_A_CHDA501_0","FERROCHELATASE, MITOCHONDRIAL","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",5,"LEU B   4;ILE B  29;LEU B  55;PRO B  56;VAL B  59","None;None;None;None;PEG B 201 ( 4.8A)","1.08A","2pnjA-4y5xB:undetectable","2pnjA-4y5xB:18.25"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"LEU B  40;VAL B 109;ILE B  76;PHE B  63","None;None;None;PEG B 201 (-4.7A)","0.97A","2weyB-4y5xB:undetectable","2weyB-4y5xB:15.45"],["3DQR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.95A","3dqrA-4y5xB:undetectable;3dqrB-4y5xB:undetectable","3dqrA-4y5xB:14.45;3dqrB-4y5xB:14.45"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.98A","3dqrA-4y5xB:undetectable;3dqrB-4y5xB:undetectable","3dqrA-4y5xB:14.45;3dqrB-4y5xB:14.45"],["3JX2_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.89A","3jx2A-4y5xB:undetectable;3jx2B-4y5xB:undetectable","3jx2A-4y5xB:14.45;3jx2B-4y5xB:14.45"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.91A","3jx2A-4y5xB:undetectable;3jx2B-4y5xB:undetectable","3jx2A-4y5xB:14.45;3jx2B-4y5xB:14.45"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.94A","3jx3A-4y5xB:undetectable;3jx3B-4y5xB:undetectable","3jx3A-4y5xB:14.45;3jx3B-4y5xB:14.45"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.90A","3jx3A-4y5xB:undetectable;3jx3B-4y5xB:undetectable","3jx3A-4y5xB:14.45;3jx3B-4y5xB:14.45"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.93A","3jx4A-4y5xB:undetectable;3jx4B-4y5xB:undetectable","3jx4A-4y5xB:14.45;3jx4B-4y5xB:14.45"],["3JX5_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.90A","3jx5A-4y5xB:undetectable;3jx5B-4y5xB:undetectable","3jx5A-4y5xB:14.45;3jx5B-4y5xB:14.45"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.91A","3jx5A-4y5xB:undetectable;3jx5B-4y5xB:undetectable","3jx5A-4y5xB:14.45;3jx5B-4y5xB:14.45"],["3JX6_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.83A","3jx6A-4y5xB:undetectable;3jx6B-4y5xB:undetectable","3jx6A-4y5xB:14.45;3jx6B-4y5xB:14.45"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.87A","3jx6A-4y5xB:undetectable;3jx6B-4y5xB:undetectable","3jx6A-4y5xB:14.45;3jx6B-4y5xB:14.45"],["3NLJ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.85A","3nljA-4y5xB:undetectable;3nljB-4y5xB:undetectable","3nljA-4y5xB:14.45;3nljB-4y5xB:14.45"],["3NLJ_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.87A","3nljA-4y5xB:undetectable;3nljB-4y5xB:undetectable","3nljA-4y5xB:14.45;3nljB-4y5xB:14.45"],["3NLP_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.88A","3nlpA-4y5xB:undetectable;3nlpB-4y5xB:undetectable","3nlpA-4y5xB:14.45;3nlpB-4y5xB:14.45"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.92A","3nlpA-4y5xB:undetectable;3nlpB-4y5xB:undetectable","3nlpA-4y5xB:14.45;3nlpB-4y5xB:14.45"],["3NLQ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.85A","3nlqA-4y5xB:undetectable;3nlqB-4y5xB:undetectable","3nlqA-4y5xB:14.45;3nlqB-4y5xB:14.45"],["3NLQ_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.88A","3nlqA-4y5xB:undetectable;3nlqB-4y5xB:undetectable","3nlqA-4y5xB:14.45;3nlqB-4y5xB:14.45"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.88A","3nlrA-4y5xB:undetectable;3nlrB-4y5xB:undetectable","3nlrA-4y5xB:14.45;3nlrB-4y5xB:14.45"],["3NLR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.91A","3nlrA-4y5xB:undetectable;3nlrB-4y5xB:undetectable","3nlrA-4y5xB:14.45;3nlrB-4y5xB:14.45"],["4CX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.93A","4cx3A-4y5xB:undetectable;4cx3B-4y5xB:undetectable","4cx3A-4y5xB:14.45;4cx3B-4y5xB:14.45"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.91A","4cx3A-4y5xB:undetectable;4cx3B-4y5xB:undetectable","4cx3A-4y5xB:14.45;4cx3B-4y5xB:14.45"],["4CX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.94A","4cx4A-4y5xB:undetectable;4cx4B-4y5xB:undetectable","4cx4A-4y5xB:14.45;4cx4B-4y5xB:14.45"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.92A","4cx4A-4y5xB:undetectable;4cx4B-4y5xB:undetectable","4cx4A-4y5xB:14.45;4cx4B-4y5xB:14.45"],["4QGI_A_ROCA101_1","PROTEASE","4y5x","DIABODY 310 VL DOMAIN","Homo sapiens",5,"GLY A 105;ALA A 104;ILE A  51;THR A  58;VAL A  37","None","0.86A","4qgiA-4y5xA:undetectable","4qgiA-4y5xA:19.57"],["4XDT_A_ACTA409_0","FAD:PROTEIN FMN TRANSFERASE","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B  18;ILE B  20;VAL B 107;THR B 105","None","0.73A","4xdtA-4y5xB:undetectable","4xdtA-4y5xB:15.63"],["5ACL_A_SASA1111_1","MCG","4y5x","DIABODY 310 VH DOMAIN;DIABODY 310 VL DOMAIN","Homo sapiens",4,"TYR A 109;TYR B  37;TYR B  50;PRO B  56","None","0.80A","5aclA-4y5xA:13.3","5aclA-4y5xA:31.94"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.86A","5addA-4y5xB:undetectable;5addB-4y5xB:undetectable","5addA-4y5xB:14.45;5addB-4y5xB:14.45"],["5ADE_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.85A","5adeA-4y5xB:undetectable;5adeB-4y5xB:undetectable","5adeA-4y5xB:14.45;5adeB-4y5xB:14.45"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"VAL B 109;ARG B  62;VAL B  18;GLU B  84","None","0.91A","5g0pA-4y5xB:undetectable;5g0pB-4y5xB:undetectable","5g0pA-4y5xB:14.45;5g0pB-4y5xB:14.45"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"GLU B  84;VAL B 109;ARG B  62;VAL B  18","None","0.92A","5g0pA-4y5xB:undetectable;5g0pB-4y5xB:undetectable","5g0pA-4y5xB:14.45;5g0pB-4y5xB:14.45"],["5L5F_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4y5x","DIABODY 310 VH DOMAIN","Homo sapiens",4,"THR B  19;SER B  64;ALA B  72;ASP B  52","None","1.08A","5l5fY-4y5xB:undetectable;5l5fZ-4y5xB:undetectable","5l5fY-4y5xB:19.63;5l5fZ-4y5xB:17.81"]]